ACI Worldwide, Inc. to Release Financial Results for the Quarter Ending March 31, 2025
Conference Call Scheduled for Thursday, May 8, 2025, at 8:30 a.m. ET OMAHA, Neb.–(BUSINESS WIRE)–ACI Worldwide (NASDAQ: ACIW), an original innovator... Read more.
HighField Biopharmaceuticals Files INDs for Two ADCplex™ Immunoliposomes with Different Cancer Killing Payloads to Overcome Limitations of Current ADCs
The new technology behind HighField’s immunoliposomes may offer greater safety and efficacy than existing antibody drug conjugates (ADCs) HANGZHOU, China–(BUSINESS... Read more.
Anaergia and Capwatt Sign Binding Letter of Intent for Nine New Biogas Plants in Europe
Follow-up agreement builds on past cooperation between the companies TREVIGLIO, Italy & BURLINGTON, Ontario–(BUSINESS WIRE)–Anaergia Inc. (“Anaergia”,... Read more.
EXPANDED CLASS PERIOD: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Fluence Energy, Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Class Action Lawsuit – FLNC
SAN DIEGO–(BUSINESS WIRE)–Robbins Geller Rudman & Dowd LLP announces that purchasers of Fluence Energy, Inc. (NASDAQ: FLNC) Class A common stock... Read more.
Trivest Announces Sale of Epika Fleet Services
MIAMI–(BUSINESS WIRE)–Trivest Partners LP (“Trivest” or the “Firm”), a leading private equity firm focused on investing in founder- and family-owned... Read more.
7 Major Markets Epidermolysis Bullosa Epidemiology Forecasts Report, 2020-2024 & 2034 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Epidermolysis Bullosa – Epidemiology Forecast – 2034” report has been added to ResearchAndMarkets.com‘s... Read more.
LTC Announces David Boitano as New Chief Investment Officer
— Seniors Housing and Health Care Industry Veteran Adds Substantial Depth and Experience to LTC Team — WESTLAKE VILLAGE, Calif.–(BUSINESS WIRE)–LTC... Read more.
Belkin Achieves Carbon Neutrality in Scope 1 and Scope 2 Emissions
The company’s 2024 Impact Report showcases bold sustainability progress and innovation LOS ANGELES–(BUSINESS WIRE)–Belkin, a leading consumer electronics... Read more.
ENHERTU® Plus Pertuzumab Demonstrated Highly Statistically Significant and Clinically Meaningful Improvement in Progression-Free Survival Versus THP as First-Line Therapy for Patients with HER2 Positive Metastatic Breast Cancer
DESTINY-Breast09 phase 3 trial of Daiichi Sankyo and AstraZeneca’s ENHERTU is the first trial in more than a decade to demonstrate superior efficacy across a broad... Read more.
Saudi Arabia’s Cultural Development Fund Participates in Expo 2025 Osaka
RIYADH, Saudi Arabia–(BUSINESS WIRE)–The Saudi Cultural Development Fund (CDF) has announced its participation in Expo 2025 Osaka as part of the Saudi... Read more.